LON:DOCS Dr. Martens (DOCS) Share Forecast, Price & News GBX 135.50 -2.60 (-1.88%) (As of 10/3/2023 ET) Add Compare Share Share Today's Range 135.50▼ 139.5050-Day Range 135.90▼ 159.8052-Week Range 113▼ 295.21Volume1.69 million shsAverage Volume2.04 million shsMarket Capitalization£1.34 billionP/E Ratio1,042.31Dividend Yield4.43%Price TargetGBX 221.25 ProfileProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlinesProfileAnalyst RatingsChartCompetitorsDividendInsider TradesHeadlines Dr. Martens MarketRank™ ForecastAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside63.3% UpsideGBX 221.25 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares£40.01 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.44 out of 5 stars 3.4 Analyst's Opinion Consensus RatingDr. Martens has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 221.25, Dr. Martens has a forecasted upside of 63.3% from its current price of GBX 135.50.Amount of Analyst CoverageDr. Martens has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for DOCS. Previous Next 1.7 Dividend Strength Dividend LeadershipDr. Martens is a leading dividend payer. It pays a dividend yield of 4.13%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthDr. Martens does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Dr. Martens is 4,615.38%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DOCS. Previous Next 1.9 News and Social Media Coverage News SentimentDr. Martens has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Cyclical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Dr. Martens this week, compared to 1 article on an average week.Search InterestOnly 10 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -58% compared to the previous 30 days.MarketBeat Follows1 people have added Dr. Martens to their MarketBeat watchlist in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Dr. Martens insiders have bought more of their company's stock than they have sold. Specifically, they have bought £400,132.24 in company stock and sold GBX 0 in company stock.Percentage Held by InsidersOnly 3.89% of the stock of Dr. Martens is held by insiders.Percentage Held by Institutions73.24% of the stock of Dr. Martens is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Dr. Martens is 1,045.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 116.92.Price to Earnings Ratio vs. SectorThe P/E ratio of Dr. Martens is 1,045.38, which means that it is trading at a more expensive P/E ratio than the Consumer Cyclical sector average P/E ratio of about 386.87.Price to Earnings Growth RatioDr. Martens has a PEG Ratio of 0.04. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioDr. Martens has a P/B Ratio of 3.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Dr. Martens (LON:DOCS) StockDr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.Read More DOCS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DOCS Stock News HeadlinesSeptember 27, 2023 | americanbankingnews.comDr. Martens (LON:DOCS) Trading 1.3% Higher September 26, 2023 | yahoo.comEditors’ picks: 15 things Yahoo staffers tried and loved in SeptemberOctober 3, 2023 | Oxford Club (Ad)The Ultimate Passive Income PlayThe #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas.September 21, 2023 | msn.comGame Commission may release 300 American martens in Pennsylvania, pending public reviewSeptember 15, 2023 | msn.comBootmaker Dr Martens to offer shoe repairs in sustainability pushSeptember 11, 2023 | msn.com10 Doc Marten dupes that will get you more boot for your buckSeptember 6, 2023 | ca.style.yahoo.comDr. Martens boots are a celebrity staple for fall — and we have the proofAugust 23, 2023 | yahoo.comWoman uses unique hack to break in Doc Marten boots without wearing themOctober 3, 2023 | Legacy Research (Ad)Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”August 15, 2023 | uk.investing.comDr. Martens PLC (DOCS)August 8, 2023 | msn.comHow Dr. Martens’ Adrian Loafers Became TikTok’s Favourite Slip-OnsAugust 8, 2023 | uk.movies.yahoo.comA shrewd insider is buying this FTSE 250 stockAugust 3, 2023 | msn.comGen Z fashion trends are shaking up the office. From Doc Martens to pocket squares, here's what 11 workers are wearing this summer.August 2, 2023 | uk.news.yahoo.comWith an activist on board, is it time to buy Dr. Martens shares?August 2, 2023 | msn.comDr. Martens Highlights Artistic Redesigns: Celebrating Gender DiversityAugust 1, 2023 | msn.comDr Martens slammed over boots showing person with breast removal scarsAugust 1, 2023 | dailymail.co.ukThe 'immoral' brands pushing body mutilation on girls: How Costa Coffee, Oxfam, Dr Martens and Penguin Books have used cartoon images to 'trivialise' life-changing trans 'top ...July 31, 2023 | msn.comDoc Martens spotlights 'alarming' DIY shoes promoting gender transition 'top surgery'July 31, 2023 | msn.comDr. Martens stock leads European gains after report of activist investor buyingJuly 31, 2023 | msn.comActivist fund Sparta builds stake in Dr Martens after share price slumpJuly 31, 2023 | msn.comBootmaker Dr Martens gains on report of stake building by activist investorJuly 27, 2023 | bizjournals.comDr. Martens to target American sales after regional strugglesJuly 25, 2023 | msn.comDown 26% in 2023, is the Dr Martens share price a screaming buy signal?July 24, 2023 | msn.comShould I buy Dr Martens shares today?July 18, 2023 | finance.yahoo.comDr. Martens plc's (LON:DOCS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?July 11, 2023 | msn.comDr. Marten’s Drop to the Lowest Price of The Year on Amazon (Up to 40% Off)June 16, 2023 | finance.yahoo.comRetailers Are Trying to Fix Their Supply-Chain ForecastsSee More Headlines Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Company Calendar Ex-Dividend for 7/18 Dividend6/08/2023Dividend Payable7/18/2023Today10/03/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Footwear & Accessories Sub-IndustryN/A SectorConsumer Cyclical Current SymbolLON:DOCS CUSIPN/A CIKN/A Webwww.drmartensplc.com Phone44 12 1415 7047FaxN/AEmployees2,591Year FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 221.25 High Stock Price ForecastGBX 350 Low Stock Price ForecastGBX 175 Forecasted Upside/Downside+62.8%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.13 Trailing P/E Ratio1,045.38 Forward P/E Ratio12.57 P/E Growth0.04Net Income£128.90 million Net Margins12.89% Pretax MarginN/A Return on Equity35.20% Return on Assets12.88% Debt Debt-to-Equity Ratio110.29 Current Ratio3.09 Quick Ratio1.13 Sales & Book Value Annual Sales£1 billion Price / Sales1.34 Cash FlowGBX 9.51 per share Price / Cash Flow14.29 Book ValueGBX 40 per share Price / Book3.40Miscellaneous Outstanding Shares988,400,000Free FloatN/AMarket Cap£1.34 billion OptionableNot Optionable Beta0.07 10 Best Stocks to Own in 2023Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Kenneth Wilson (Age 56)CEO & Director Comp: $773kMr. Jon William Mortimore (Age 56)CFO & Director Comp: $503kMr. Geert Peeters (Age 57)Chief Operating Officer Mr. Ronald GarricksChief Information OfficerMs. Meg JohnsonChief Marketing OfficerMs. Emily Clare Reichwald (Age 48)Chief People & Sustainability Officer and Company Sec. Mr. Sean O'NeillChief Digital OfficerMr. Derek ChanPres of APACMr. Adam M. MeekChief Product OfficerMs. Jennifer SomerPres of AmericasMore ExecutivesKey CompetitorsPlaytechLON:PTECWatches of Switzerland GroupLON:WOSGCarnival Co. &LON:CCLDowlais GroupLON:DWLMitchells & ButlersLON:MABView All CompetitorsInsidersJon MortimoreBought 97 shares on 8/11/2023Total: £14,938.00 ($154.00/share)Kenny WilsonBought 309,948 shares on 7/14/2023Total: £39.98 M ($129.00/share)Jon MortimoreBought 119 shares on 7/11/2023Total: £14,994.00 ($126.00/share)Jon MortimoreBought 116 shares on 6/12/2023Total: £15,080.00 ($130.00/share)Robyn PerrissBought 5,000 shares on 6/7/2023Total: £680,000.00 ($136.00/share)View All Insider Transactions DOCS Stock - Frequently Asked Questions Should I buy or sell Dr. Martens stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Dr. Martens in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DOCS shares. View DOCS analyst ratings or view top-rated stocks. What is Dr. Martens' stock price forecast for 2023? 4 Wall Street research analysts have issued 12 month price targets for Dr. Martens' shares. Their DOCS share price forecasts range from GBX 175 to GBX 350. On average, they expect the company's stock price to reach GBX 221.25 in the next twelve months. This suggests a possible upside of 62.8% from the stock's current price. View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts. How have DOCS shares performed in 2023? Dr. Martens' stock was trading at GBX 190.60 at the start of the year. Since then, DOCS stock has decreased by 28.7% and is now trading at GBX 135.90. View the best growth stocks for 2023 here. How often does Dr. Martens pay dividends? What is the dividend yield for Dr. Martens? Dr. Martens declared a dividend on Thursday, June 1st. Investors of record on Thursday, June 8th will be given a dividend of GBX 4.28 per share on Tuesday, July 18th. This represents a yield of 2.74%. The ex-dividend date is Thursday, June 8th. This is a boost from the stock's previous dividend of GBX 1.56. The official announcement can be seen at this link. Read our dividend analysis for DOCS. Is Dr. Martens a good dividend stock? Dr. Martens (LON:DOCS) pays an annual dividend of GBX 6 per share and currently has a dividend yield of 4.13%. DOCS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 4,615.38%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for DOCS. What is Dr. Martens' stock symbol? Dr. Martens trades on the London Stock Exchange (LON) under the ticker symbol "DOCS." How do I buy shares of Dr. Martens? Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Dr. Martens' stock price today? One share of DOCS stock can currently be purchased for approximately GBX 135.90. How much money does Dr. Martens make? Dr. Martens (LON:DOCS) has a market capitalization of £1.34 billion and generates £1 billion in revenue each year. The company earns £128.90 million in net income (profit) each year or GBX 0.13 on an earnings per share basis. How many employees does Dr. Martens have? The company employs 2,591 workers across the globe. How can I contact Dr. Martens? Dr. Martens' mailing address is 28 Jamestown Road, Camden, London NW1 7BY, United Kingdom. The official website for the company is www.drmartensplc.com. The company can be reached via phone at 44 12 1415 7047. This page (LON:DOCS) was last updated on 10/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.